What is the recommended dose of antihistamine (diphenhydramine) syrup for pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diphenhydramine Dosing for Pediatric Patients

For children under 6 years of age, diphenhydramine syrup should not be used according to FDA labeling. 1

Age-Based Dosing Recommendations

Children Under 6 Years

  • Do not use diphenhydramine syrup in this age group per FDA labeling 1
  • Safety concerns include potential toxicity and serious adverse events including fatalities reported in this age group 2
  • The FDA's Nonprescription Drugs and Pediatric Advisory Committees recommended against using OTC cough and cold medications containing antihistamines in children under 6 years due to safety concerns 2

Children 6 to Under 12 Years

  • Dose: 10 mL (25 mg) per dose 1
  • Administer every 4-6 hours as needed
  • Do not exceed 6 doses (150 mg) in 24 hours
  • For anaphylaxis management (when used as adjunctive therapy): 1-2 mg/kg or 25 mg per dose parenterally 2

Children 12 Years and Older

  • Dose: 10-20 mL (25-50 mg) per dose 1
  • Administer every 4-6 hours as needed
  • Do not exceed 6 doses (300 mg) in 24 hours
  • For anaphylaxis management (when used as adjunctive therapy): 25-50 mg per dose 2, 3

Important Considerations

Safety Concerns

  • Diphenhydramine and other first-generation antihistamines can cause significant sedation in over 50% of patients receiving therapeutic doses 4
  • Between 1969 and 2006,69 fatalities were associated with antihistamines (including 33 with diphenhydramine) in children under 6 years 2
  • Common causes of adverse events include:
    • Use of multiple cold/cough products containing antihistamines
    • Medication errors
    • Accidental exposures
    • Intentional overdose 2

Clinical Pearls

  • Diphenhydramine is considered a second-line therapy for anaphylaxis and should never be administered alone in anaphylaxis treatment 2
  • H1 antihistamines are only effective for cutaneous symptoms (urticaria, pruritus, flushing) and should not delay epinephrine administration in anaphylaxis 3
  • The combination of H1 (diphenhydramine) and H2 (ranitidine) antagonists is superior to diphenhydramine alone for urticaria 2, 3

Monitoring

  • Monitor for sedation, which may affect learning ability in children 4
  • First-generation antihistamines like diphenhydramine can cause paradoxical behavioral disinhibition, especially in younger children and those with developmental disabilities 2

Alternative Options

  • Second-generation antihistamines (cetirizine, desloratadine, fexofenadine, levocetirizine, and loratadine) have been shown to be well-tolerated with a better safety profile in young children 2, 5
  • Consider these newer agents particularly for children under 6 years of age where diphenhydramine is not recommended 2

Remember that pediatric patients require individualized dosing based on age, size, and organ maturity—not simply reduced adult doses 6. When administering diphenhydramine to children, always follow the FDA-approved dosing guidelines and be vigilant for potential adverse effects.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Anaphylaxis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Antihistamines: ABC for the pediatricians.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2020

Research

Dosing considerations in the pediatric patient.

Clinical therapeutics, 1991

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.